Showing results (41-50 of 118) with videos related to
Sort By:
Pageof 12
Journal of Neuro-Oncology|November 11, 2018
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastomaMatthias Holdhoff, Xiaobu Ye, Anna F Piotrowski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Detection of tumor DNA at the margins of colorectal cancer liver metastasisMatthias Holdhoff, Kerstin Schmidt, Frank Diehl, et al.Frontiers in Oncology|August 12, 2022
Current and Future Frontiers of Molecularly Defined OligodendrogliomasJordina Rincon-Torroella, Maureen Rakovec, Josh Materi, et al.Blood Cells, Molecules & Diseases|February 25, 2005
Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptorMatthias Holdhoff, Karl-Anton Kreuzer, Christine Appelt, et al.Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.Journal of Neuro-Oncology|October 18, 2019
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.American Journal of Hematology|July 25, 2003
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcomePhilipp Le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.Advances in Radiation Oncology|October 30, 2018
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvageColette J Shen, Megan N Kummerlowe, Kristin J Redmond, et al.Journal of Neuro-Oncology|November 24, 2019
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.Journal of Neuro-Oncology|October 30, 2024
Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastomaLucy Chen, Emanuelle Rizk, Mohamed Sherief, et al.Pageof 12